Literature DB >> 2835504

RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2.

J G Keck1, L H Soe, S Makino, S A Stohlman, M M Lai.   

Abstract

It has previously been shown that the murine coronavirus mouse hepatitis virus (MHV) undergoes RNA recombination at a relatively high frequency in both tissue culture and infected animals. Thus far, all of the recombination sites had been localized at the 5' half of the RNA genome. We have now performed a cross between MHV-2, a fusion-negative murine coronavirus, and a temperature-sensitive mutant of the A59 strain of MHV, which is fusion positive at the permissive temperature. By selecting fusion-positive viruses at the nonpermissive temperature, we isolated several recombinants containing multiple crossovers in a single genome. Some of the recombinants became fusion negative during the plaque purification. The fusion ability of the recombinants parallels the presence or absence of the A59 genomic sequences encoding peplomers. Several of the recombinants have crossovers within 3' end genes which encode viral structural proteins, N and E1. These recombination sites were not specifically selected with the selection markers used. This finding, together with results of previous recombination studies, indicates that RNA recombination can occur almost anywhere from the 5' end to the 3' end along the entire genome. The data also show that the replacement of A59 genetic sequences at the 5' end of gene C, which encodes the peplomer protein, with the fusion-negative MHV-2 sequences do not affect the fusion ability of the recombinant viruses. Thus, the crucial determinant for the fusion-inducing capability appears to reside in the more carboxyl portion of the peplomer protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835504      PMCID: PMC253283          DOI: 10.1128/JVI.62.6.1989-1998.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Phosphoproteins of murine hepatitis viruses.

Authors:  S A Stohlman; M M Lai
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

2.  Genomic RNA of the murine coronavirus JHM.

Authors:  H Wege; A Müller; V ter Meulen
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

3.  RNA of mouse hepatitis virus.

Authors:  M M Lai; S A Stohlman
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Extraction of nucleic acids from agarose gels.

Authors:  J Langridge; P Langridge; P L Bergquist
Journal:  Anal Biochem       Date:  1980-04       Impact factor: 3.365

6.  Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid.

Authors:  L S Sturman; K V Holmes; J Behnke
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  RNA-binding proteins of coronavirus MHV: detection of monomeric and multimeric N protein with an RNA overlay-protein blot assay.

Authors:  S G Robbins; M F Frana; J J McGowan; J F Boyle; K V Holmes
Journal:  Virology       Date:  1986-04-30       Impact factor: 3.616

9.  Characterization of coronavirus II. Glycoproteins of the viral envelope: tryptic peptide analysis.

Authors:  L S Sturman; K V Holmes
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

10.  I. Structural proteins: effects of preparative conditions on the migration of protein in polyacrylamide gels.

Authors:  L S Sturman
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

View more
  47 in total

Review 1.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

2.  Prevalence and genetic diversity of coronaviruses in bats from China.

Authors:  X C Tang; J X Zhang; S Y Zhang; P Wang; X H Fan; L F Li; G Li; B Q Dong; W Liu; C L Cheung; K M Xu; W J Song; D Vijaykrishna; L L M Poon; J S M Peiris; G J D Smith; H Chen; Y Guan
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 3.  The polymerase in its labyrinth: mechanisms and implications of RNA recombination.

Authors:  T C Jarvis; K Kirkegaard
Journal:  Trends Genet       Date:  1991-06       Impact factor: 11.639

4.  The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells.

Authors:  D W Yoo; M D Parker; L A Babiuk
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

5.  High-frequency leader sequence switching during coronavirus defective interfering RNA replication.

Authors:  S Makino; M M Lai
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombination-resistant genome.

Authors:  Boyd Yount; Rhonda S Roberts; Lisa Lindesmith; Ralph S Baric
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

7.  A mechanism of virus-induced demyelination.

Authors:  Jayasri Das Sarma
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-21

8.  Murine coronavirus replication induces cell cycle arrest in G0/G1 phase.

Authors:  Chun-Jen Chen; Shinji Makino
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  The gene encoding the nucleocapsid protein: sequence analysis in murine hepatitis virus type 3 and evolution in Coronaviridae.

Authors:  D Décimo; H Philippe; M Hadchouel; M Tardieu; M Meunier-Rotival
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  The spike protein of murine coronavirus regulates viral genome transport from the cell surface to the endoplasmic reticulum during infection.

Authors:  Hongqing Zhu; Dongdong Yu; Xuming Zhang
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.